Page last updated: 2024-10-29

ketamine and Hirschsprung Disease

ketamine has been researched along with Hirschsprung Disease in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keshtgar, AS1
Choudhry, MS1
Kufeji, D1
Ward, HC1
Clayden, GS1

Other Studies

1 other study available for ketamine and Hirschsprung Disease

ArticleYear
Anorectal manometry with and without ketamine for evaluation of defecation disorders in children.
    Journal of pediatric surgery, 2015, Volume: 50, Issue:3

    Topics: Adolescent; Anal Canal; Analgesics; Biofeedback, Psychology; Child; Child, Preschool; Constipation;

2015